Global Oncology Small Molecule Drugs Market Research Report 2023

Report ID: 1877137 | Published Date: Jan 2026 | No. of Page: 108 | Base Year: 2025 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Chemotherapy Drugs
        1.2.3 Immunomodulating Drugs
        1.2.4 Targeted Therapy Drugs
        1.2.5 Hormonal Therapy
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Oncology Small Molecule Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Lung Cancer
        1.3.7 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oncology Small Molecule Drugs Market Perspective (2017-2028)
    2.2 Oncology Small Molecule Drugs Growth Trends by Region
        2.2.1 Oncology Small Molecule Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oncology Small Molecule Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Oncology Small Molecule Drugs Market Dynamics
        2.3.1 Oncology Small Molecule Drugs Industry Trends
        2.3.2 Oncology Small Molecule Drugs Market Drivers
        2.3.3 Oncology Small Molecule Drugs Market Challenges
        2.3.4 Oncology Small Molecule Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oncology Small Molecule Drugs Players by Revenue
        3.1.1 Global Top Oncology Small Molecule Drugs Players by Revenue (2017-2022)
        3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oncology Small Molecule Drugs Revenue
    3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio
        3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2021
    3.5 Oncology Small Molecule Drugs Key Players Head office and Area Served
    3.6 Key Players Oncology Small Molecule Drugs Product Solution and Service
    3.7 Date of Enter into Oncology Small Molecule Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Small Molecule Drugs Breakdown Data by Type
    4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028)
5 Oncology Small Molecule Drugs Breakdown Data by Application
    5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oncology Small Molecule Drugs Market Size (2017-2028)
    6.2 North America Oncology Small Molecule Drugs Market Size by Country (2017-2022)
    6.3 North America Oncology Small Molecule Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Oncology Small Molecule Drugs Market Size (2017-2028)
    7.2 Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022)
    7.3 Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oncology Small Molecule Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Oncology Small Molecule Drugs Market Size (2017-2028)
    9.2 Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022)
    9.3 Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oncology Small Molecule Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Detail
        11.1.2 Roche Business Overview
        11.1.3 Roche Oncology Small Molecule Drugs Introduction
        11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.1.5 Roche Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Detail
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Oncology Small Molecule Drugs Introduction
        11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.2.5 Novartis Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Oncology Small Molecule Drugs Introduction
        11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Celgene
        11.4.1 Celgene Company Detail
        11.4.2 Celgene Business Overview
        11.4.3 Celgene Oncology Small Molecule Drugs Introduction
        11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.4.5 Celgene Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Detail
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction
        11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Amgen
        11.6.1 Amgen Company Detail
        11.6.2 Amgen Business Overview
        11.6.3 Amgen Oncology Small Molecule Drugs Introduction
        11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.6.5 Amgen Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Detail
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction
        11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.7.5 Johnson & Johnson Recent Development
    11.8 AbbVie
        11.8.1 AbbVie Company Detail
        11.8.2 AbbVie Business Overview
        11.8.3 AbbVie Oncology Small Molecule Drugs Introduction
        11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.8.5 AbbVie Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Detail
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Oncology Small Molecule Drugs Introduction
        11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.9.5 Sanofi Recent Development
    11.10 Takeda
        11.10.1 Takeda Company Detail
        11.10.2 Takeda Business Overview
        11.10.3 Takeda Oncology Small Molecule Drugs Introduction
        11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.10.5 Takeda Recent Development
    11.11 Eli Lilly
        11.11.1 Eli Lilly Company Detail
        11.11.2 Eli Lilly Business Overview
        11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction
        11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.11.5 Eli Lilly Recent Development
    11.12 Bayer
        11.12.1 Bayer Company Detail
        11.12.2 Bayer Business Overview
        11.12.3 Bayer Oncology Small Molecule Drugs Introduction
        11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.12.5 Bayer Recent Development
    11.13 AstraZeneca
        11.13.1 AstraZeneca Company Detail
        11.13.2 AstraZeneca Business Overview
        11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction
        11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.13.5 AstraZeneca Recent Development
    11.14 Astellas
        11.14.1 Astellas Company Detail
        11.14.2 Astellas Business Overview
        11.14.3 Astellas Oncology Small Molecule Drugs Introduction
        11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.14.5 Astellas Recent Development
    11.15 Merck
        11.15.1 Merck Company Detail
        11.15.2 Merck Business Overview
        11.15.3 Merck Oncology Small Molecule Drugs Introduction
        11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.15.5 Merck Recent Development
    11.16 Biogen Idec
        11.16.1 Biogen Idec Company Detail
        11.16.2 Biogen Idec Business Overview
        11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction
        11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.16.5 Biogen Idec Recent Development
    11.17 Eisai
        11.17.1 Eisai Company Detail
        11.17.2 Eisai Business Overview
        11.17.3 Eisai Oncology Small Molecule Drugs Introduction
        11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.17.5 Eisai Recent Development
    11.18 Teva
        11.18.1 Teva Company Detail
        11.18.2 Teva Business Overview
        11.18.3 Teva Oncology Small Molecule Drugs Introduction
        11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.18.5 Teva Recent Development
    11.19 Otsuka
        11.19.1 Otsuka Company Detail
        11.19.2 Otsuka Business Overview
        11.19.3 Otsuka Oncology Small Molecule Drugs Introduction
        11.19.4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.19.5 Otsuka Recent Development
    11.20 Ipsen
        11.20.1 Ipsen Company Detail
        11.20.2 Ipsen Business Overview
        11.20.3 Ipsen Oncology Small Molecule Drugs Introduction
        11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.20.5 Ipsen Recent Development
    11.21 Gilead Sciences
        11.21.1 Gilead Sciences Company Detail
        11.21.2 Gilead Sciences Business Overview
        11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction
        11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.21.5 Gilead Sciences Recent Development
    11.22 Exelixis
        11.22.1 Exelixis Company Detail
        11.22.2 Exelixis Business Overview
        11.22.3 Exelixis Oncology Small Molecule Drugs Introduction
        11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022)
        11.22.5 Exelixis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Chemotherapy Drugs
    Table 3. Key Players of Immunomodulating Drugs
    Table 4. Key Players of Targeted Therapy Drugs
    Table 5. Key Players of Hormonal Therapy
    Table 6. Key Players of Other
    Table 7. Global Oncology Small Molecule Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Oncology Small Molecule Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Oncology Small Molecule Drugs Market Share by Region (2017-2022)
    Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Oncology Small Molecule Drugs Market Share by Region (2023-2028)
    Table 13. Oncology Small Molecule Drugs Market Trends
    Table 14. Oncology Small Molecule Drugs Market Drivers
    Table 15. Oncology Small Molecule Drugs Market Challenges
    Table 16. Oncology Small Molecule Drugs Market Restraints
    Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Oncology Small Molecule Drugs Market Share by Players (2017-2022)
    Table 19. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021)
    Table 20. Ranking of Global Top Oncology Small Molecule Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oncology Small Molecule Drugs Product Solution and Service
    Table 24. Date of Enter into Oncology Small Molecule Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Oncology Small Molecule Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Oncology Small Molecule Drugs Revenue Market Share by Application (2017-2022)
    Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Oncology Small Molecule Drugs Revenue Market Share by Application (2023-2028)
    Table 34. North America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Roche Company Detail
    Table 45. Roche Business Overview
    Table 46. Roche Oncology Small Molecule Drugs Product
    Table 47. Roche Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 48. Roche Recent Development
    Table 49. Novartis Company Detail
    Table 50. Novartis Business Overview
    Table 51. Novartis Oncology Small Molecule Drugs Product
    Table 52. Novartis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 53. Novartis Recent Development
    Table 54. Pfizer Company Detail
    Table 55. Pfizer Business Overview
    Table 56. Pfizer Oncology Small Molecule Drugs Product
    Table 57. Pfizer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 58. Pfizer Recent Development
    Table 59. Celgene Company Detail
    Table 60. Celgene Business Overview
    Table 61. Celgene Oncology Small Molecule Drugs Product
    Table 62. Celgene Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 63. Celgene Recent Development
    Table 64. Bristol-Myers Squibb Company Detail
    Table 65. Bristol-Myers Squibb Business Overview
    Table 66. Bristol-Myers Squibb Oncology Small Molecule Drugs Product
    Table 67. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 68. Bristol-Myers Squibb Recent Development
    Table 69. Amgen Company Detail
    Table 70. Amgen Business Overview
    Table 71. Amgen Oncology Small Molecule Drugs Product
    Table 72. Amgen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 73. Amgen Recent Development
    Table 74. Johnson & Johnson Company Detail
    Table 75. Johnson & Johnson Business Overview
    Table 76. Johnson & Johnson Oncology Small Molecule Drugs Product
    Table 77. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 78. Johnson & Johnson Recent Development
    Table 79. AbbVie Company Detail
    Table 80. AbbVie Business Overview
    Table 81. AbbVie Oncology Small Molecule Drugs Product
    Table 82. AbbVie Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 83. AbbVie Recent Development
    Table 84. Sanofi Company Detail
    Table 85. Sanofi Business Overview
    Table 86. Sanofi Oncology Small Molecule Drugs Product
    Table 87. Sanofi Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 88. Sanofi Recent Development
    Table 89. Takeda Company Detail
    Table 90. Takeda Business Overview
    Table 91. Takeda Oncology Small Molecule Drugs Product
    Table 92. Takeda Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 93. Takeda Recent Development
    Table 94. Eli Lilly Company Detail
    Table 95. Eli Lilly Business Overview
    Table 96. Eli Lilly Oncology Small Molecule DrugsProduct
    Table 97. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 98. Eli Lilly Recent Development
    Table 99. Bayer Company Detail
    Table 100. Bayer Business Overview
    Table 101. Bayer Oncology Small Molecule DrugsProduct
    Table 102. Bayer Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 103. Bayer Recent Development
    Table 104. AstraZeneca Company Detail
    Table 105. AstraZeneca Business Overview
    Table 106. AstraZeneca Oncology Small Molecule DrugsProduct
    Table 107. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 108. AstraZeneca Recent Development
    Table 109. Astellas Company Detail
    Table 110. Astellas Business Overview
    Table 111. Astellas Oncology Small Molecule DrugsProduct
    Table 112. Astellas Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 113. Astellas Recent Development
    Table 114. Merck Company Detail
    Table 115. Merck Business Overview
    Table 116. Merck Oncology Small Molecule DrugsProduct
    Table 117. Merck Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 118. Merck Recent Development
    Table 119. Biogen Idec Company Detail
    Table 120. Biogen Idec Business Overview
    Table 121. Biogen Idec Oncology Small Molecule DrugsProduct
    Table 122. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 123. Biogen Idec Recent Development
    Table 124. Eisai Company Detail
    Table 125. Eisai Business Overview
    Table 126. Eisai Oncology Small Molecule DrugsProduct
    Table 127. Eisai Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 128. Eisai Recent Development
    Table 129. Teva Company Detail
    Table 130. Teva Business Overview
    Table 131. Teva Oncology Small Molecule DrugsProduct
    Table 132. Teva Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 133. Teva Recent Development
    Table 134. Otsuka Company Detail
    Table 135. Otsuka Business Overview
    Table 136. Otsuka Oncology Small Molecule DrugsProduct
    Table 137. Otsuka Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 138. Otsuka Recent Development
    Table 139. Ipsen Company Detail
    Table 140. Ipsen Business Overview
    Table 141. Ipsen Oncology Small Molecule DrugsProduct
    Table 142. Ipsen Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 143. Ipsen Recent Development
    Table 144. Gilead Sciences Company Detail
    Table 145. Gilead Sciences Business Overview
    Table 146. Gilead Sciences Oncology Small Molecule DrugsProduct
    Table 147. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 148. Gilead Sciences Recent Development
    Table 149. Exelixis Company Detail
    Table 150. Exelixis Business Overview
    Table 151. Exelixis Oncology Small Molecule DrugsProduct
    Table 152. Exelixis Revenue in Oncology Small Molecule Drugs Business (2017-2022) & (US$ Million)
    Table 153. Exelixis Recent Development
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Small Molecule Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Chemotherapy Drugs Features
    Figure 3. Immunomodulating Drugs Features
    Figure 4. Targeted Therapy Drugs Features
    Figure 5. Hormonal Therapy Features
    Figure 6. Other Features
    Figure 7. Global Oncology Small Molecule Drugs Market Share by Application in 2021 & 2028
    Figure 8. Blood Cancer Case Studies
    Figure 9. Breast Cancer Case Studies
    Figure 10. Gastrointestinal Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Lung Cancer Case Studies
    Figure 13. Other Case Studies
    Figure 14. Oncology Small Molecule Drugs Report Years Considered
    Figure 15. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Oncology Small Molecule Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Oncology Small Molecule Drugs Market Share by Region: 2021 VS 2028
    Figure 18. Global Oncology Small Molecule Drugs Market Share by Players in 2021
    Figure 19. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Small Molecule Drugs as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2021
    Figure 21. North America Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. North America Oncology Small Molecule Drugs Market Share by Country (2017-2028)
    Figure 23. United States Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Oncology Small Molecule Drugs Market Share by Country (2017-2028)
    Figure 27. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Oncology Small Molecule Drugs Market Share by Region (2017-2028)
    Figure 35. China Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Oncology Small Molecule Drugs Market Share by Country (2017-2028)
    Figure 43. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Oncology Small Molecule Drugs Market Share by Country (2017-2028)
    Figure 47. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 50. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 51. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 52. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 54. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 55. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 56. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 57. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 58. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 59. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 60. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 61. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 62. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 63. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 64. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 65. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 66. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 67. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 68. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 69. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 70. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Novartis
Pfizer
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
AstraZeneca
Astellas
Merck
Biogen Idec
Eisai
Teva
Otsuka
Ipsen
Gilead Sciences
Exelixis
Frequently Asked Questions
Oncology Small Molecule Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Small Molecule Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Small Molecule Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Yoga Exercise Mats

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Pool Speakers

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More